アジア太平洋地域のデジタル治療（DTx）市場 – 2031年までの業界動向と予測

Customize Your Report レポートをカスタマイズする Buy Now 今すぐ購入 Free Sample Report 無料サンプルレポート
Home Healthcare IT アジア太平洋地域のデジタル治療（DTx）市場
Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

アジア太平洋地域のデジタル治療（DTx）市場 – 2031年までの業界動向と予測

  • Healthcare IT
  • Upcoming Report
  • Jun 2024
  • Asia-Pacific
  • 350 ページ
  • テーブル数: 220
  • 図の数: 60
Buy Now 今すぐ購入

アジア太平洋地域のデジタル治療（DTx）市場

Market Size in USD Billion

CAGR :  % Diagram

Diagram 予測期間
 2024 –2031
Diagram 市場規模（基準年）
 USD 3.78 Billion
Diagram Market Size (Forecast Year)
 USD 20.32 Billion
Diagram CAGR
 %
Diagram 主要市場プレーヤー
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

アジア太平洋地域のデジタル治療 (DTx) 市場、製品およびサービス タイプ別 (ハードウェア製品、ソリューション/ソフトウェア、サービス)、アプリケーション別 (治療/ケア関連アプリケーション、予防アプリケーション)、購入モード別 (グループ購入組織および個人)、販売チャネル別 (B2B および B2C) – 2031 年までの業界動向と予測。

アジア太平洋地域のデジタル治療（DTx）市場

アジア太平洋地域のデジタル治療（DTx）市場分析と規模

デジタル治療（DTx）市場は、技術の進歩により目覚ましい成長を遂げています。最新の方法では、AI、仮想現実、パーソナライズされたアルゴリズムを統合して治療効果を高めています。これらのイノベーションを活用して、DTxソリューションは精神衛生から慢性疾患まで、より幅広い病気に対応します。この進歩的な状況は、ヘルスケアの変革時代を意味し、患者の転帰とアクセス性の向上を約束します。                               

アジア太平洋地域のデジタル治療（DTx）市場規模は、2023年に37億8,000万米ドルと評価され、2031年までに203億2,000万米ドルに達すると予測されており、2024年から2031年の予測期間中に23.4％のCAGRで成長すると予想されています。これは、市場価値を示しています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、データブリッジマーケットリサーチがまとめた市場レポートには、詳細な専門家の分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

レポートの範囲と市場セグメンテーション

レポートメトリック

詳細

予測期間

2024年から2031年

基準年

2023

歴史的な年

2022 (2016～2021年にカスタマイズ可能)

定量単位

売上高（10億米ドル）、販売数量（個数）、価格（米ドル）

対象セグメント

製品およびサービスの種類（ハードウェア製品、ソリューション/ソフトウェア、サービス）、用途（治療/ケア関連アプリケーション、予防アプリケーション）、購入モード（グループ購入組織および個人）、販売チャネル（B2BおよびB2C）

対象国

中国、日本、インド、韓国、シンガポール、マレーシア、オーストラリア、タイ、インドネシア、フィリピン、その他のアジア太平洋地域 (APAC)

対象となる市場プレーヤー

Omada Health Inc. (米国)、Welldoc, Inc. (米国)、2Morrow, Inc. (米国)、Teladoc Health, Inc. (米国)、Propeller HealtH (米国)、Fitbit LLC (米国)、Canary Health (米国)、Noom, Inc. (米国)、Pear Therapeutics, Inc. (米国)、Akili Interactive Labs, Inc. (米国)、Hygieia (米国)、DarioHealth Corp. (イスラエル)、BigHealth (英国)、GAIA AG (ドイツ)、Limbix Health, Inc. (米国)、Mango Health (米国)

市場機会
  • 予防医療への注目の高まり
  • 遠隔モニタリングと遠隔医療の台頭

市場の定義

Digital therapeutics (DTx) are software-based interventions designed to treat, manage, or prevent medical conditions. They often employ cognitive behavioral therapy, mindfulness techniques, or other evidence-based approaches to deliver therapeutic benefits. DTx can be accessed via smartphones, tablets, or computers, offering convenient and scalable solutions for individuals seeking to improve their health and well-being.            

Asia-Pacific Digital Therapeutic (DTx) Market Dynamics

Drivers

  • Increasing Prevalence of Chronic Diseases

The surge in chronic diseases such as diabetes, cardiovascular conditions, and mental health disorders is fueling demand for convenient and efficient digital therapeutic solutions. For instance, diabetes affects millions globally, prompting the development of mobile apps such as Livongo, which offer personalized coaching and monitoring, revolutionizing disease management. This increasing prevalence underscores the urgent need for accessible digital therapies, propelling growth in the digital therapeutic market.

  • Growing Regulatory Support and Validation

Regulatory agencies such as the FDA in the US and the EMA in Europe are crucial drivers of the digital therapeutic (DTx) market. Their recognition and establishment of pathways for DTx validation and approval foster innovation and market growth. For instance, the FDA's clearance of Pear Therapeutics' reSET, the first prescription digital therapeutic for substance use disorder, underscored regulatory support, instilling confidence in investors and accelerating market adoption.

Opportunities

  • Growing Focus on Preventive Healthcare

The emphasis on preventive healthcare drives the digital therapeutic (DTx) market by leveraging behavior modification, lifestyle management, and risk reduction. For instance, DTx platforms such as Omada Health offer personalized programs targeting obesity and related conditions through dietary changes and exercise regimens. By addressing underlying risk factors early, these solutions help prevent the onset or progression of chronic diseases, driving demand for DTx interventions.

  • Rising Remote Monitoring and Telehealth

The COVID-19 pandemic catalyzed the widespread adoption of remote monitoring and telehealth solutions, fueling the growth of the digital therapeutic market. Healthcare providers swiftly embraced these technologies to deliver continuous care beyond traditional settings. For instance, companies such as Teladoc Health experienced a surge in demand for their telehealth services, demonstrating the pivotal role of remote monitoring in expanding access to healthcare and driving the uptake of digital therapeutics.  

Restraints/Challenges

  • Data Privacy and Security Concerns

Data privacy and security concerns surrounding the collection and transmission of sensitive health data can undermine trust in digital therapeutic (DTx) solutions, acting as a significant barrier to market growth. Breaches or perceived vulnerabilities in safeguarding patient information may deter both healthcare providers and patients from adopting DTx interventions.

  • Lack of Standardization

The absence of standardized protocols and guidelines for DTx development, deployment, and evaluation creates interoperability issues, quality assurance challenges, and comparability difficulties. This lack of uniformity hampers market growth by impeding seamless integration, ensuring consistent quality, and facilitating meaningful comparison between different digital therapeutic products.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In October 2023, Better Therapeutics, Inc. unveiled AspyreRx, a diabetes digital therapeutic platform tailored to enhance diabetes management. AspyreRx offers personalized experiences empowering patients in effectively managing their condition
  • In August 2023, Welldoc, Inc. attained its 10th FDA approval for BlueStar, its diabetes digital health solution, reaffirming its commitment to advancing digital healthcare
  • In November 2020, ResMed's randomized controlled trial, published in the Journal of Allergy and Clinical Immunology, showcased significant reductions in inhaler reuse and improved patient compliance with the Propeller Health digital platform, driving increased customer adoption and company valuation
  • In April 2020, Smartpatient GmbH initiated a strategic partnership with "Around the Pill" Solutions, aimed at bolstering pharmaceutical development endeavors. This collaboration is poised to yield innovative products, expand customer reach, and augment market value through enhanced product offerings and market presence

Asia-Pacific Digital Therapeutic (DTx) Market Scope

The market is segmented on the basis of product and service type, application, purchase mode and sales channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Service Type

  • Hardware Products
  • ソリューション/ソフトウェア
  • サービス

 応用

  • 治療・ケア関連アプリケーション
  • 予防的アプリケーション

 購入モード

  • グループ購入組織
  • 個人

販売チャネル

  • 企業向け
  • B2C

アジア太平洋地域のデジタル治療（DTx）市場の地域分析/洞察

市場は分析され、市場規模の洞察と傾向は、上記のように国、製品およびサービスの種類、アプリケーション、購入モード、販売チャネル別に提供されます。

市場レポートで取り上げられている国は、アジア太平洋地域 (APAC) の中国、日本、インド、韓国、シンガポール、マレーシア、オーストラリア、タイ、インドネシア、フィリピン、その他のアジア太平洋地域 (APAC) です。

急速な都市化とデジタル治療企業の台頭により、日本はアジア太平洋地域のデジタル治療（DTx）市場を支配すると予想されています。DTx製品導入の先駆者として、日本はデジタル治療をヘルスケアに統合する先駆者であり、都市開発の中で革新的なヘルスケアソリューションに取り組む国の取り組みを反映しています。

レポートの国別セクションでは、市場の現在および将来の動向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。下流および上流のバリュー チェーン分析、技術動向、ポーターの 5 つの力の分析、ケース スタディなどのデータ ポイントは、各国の市場シナリオを予測するために使用される指標の一部です。また、国別データの予測分析を提供する際には、グローバル ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、国内関税と貿易ルートの影響も考慮されます。   

ヘルスケアインフラの成長 導入ベースと新技術の浸透

この市場では、各国の医療設備支出の増加、市場向け各種製品のインストールベース、ライフライン曲線を使用した技術の影響、医療規制シナリオの変化と市場への影響など、詳細な市場分析も提供しています。データは、2016年から2021年までの履歴期間について利用可能です。

競争環境とアジア太平洋地域のデジタル治療（DTx）市場シェア分析

市場競争環境では、競合他社ごとの詳細が提供されます。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などが含まれます。提供される上記のデータ ポイントは、市場に関連する会社の焦点にのみ関連しています。

市場で活動している主要企業は次のとおりです。

  • オマダヘルス社（米国）
  • ウェルドック社（米国）
  • 2Morrow, Inc.（米国）
  • テラドック・ヘルス社（米国）
  • プロペラヘルス（米国）
  • フィットビットLLC（米国）
  • カナリーヘルス（米国）
  • Noom, Inc.（米国）
  • ペア・セラピューティクス社（米国）
  • Akili Interactive Labs, Inc.（米国）
  • ヒュギエイア（米国）
  • ダリオヘルス社（イスラエル）
  • ビッグヘルス（英国）
  • GAIA AG（ドイツ）
  • リンビックスヘルス社（米国）
  • マンゴーヘルス（米国）

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

Sample Image 画像をクリックすると拡大します
  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT AND SERVICE TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 ASIA-PACIFIC DIGITAL THERAPEUTICS (DTX) MARKET: REGULATIONS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES

5.1.2 INCREASE IN AWARENESS BY GOVERNMENT AGENCIES

5.1.3 TECHNOLOGICAL ADVANCEMENT IN HEALTHCARE

5.1.4 INCREASED NUMBER OF PEOPLE USING SMARTPHONES

5.1.5 IMPROVED QUALITY OF LIFE

5.2 RESTRAINTS

5.2.1 PATIENT INFORMATION PRIVACY POLICIES

5.2.2 DIGITAL PAYMENT ASSOCIATED WITH DIGITAL THERAPEUTICS

5.2.3 UNDER DEVELOPING COUNTIRES LACKING SMARTPHONES AND INTERNET FACILITIES

5.3 OPPORTUNITIES

5.3.1 RISING DEMAND OF DIGITAL THERAPEUTICS

5.3.2 COLLABORATION BETWEEN COMPANIES TO PROVIDE BETTER PRODUCTS/SERVICES

5.3.3 PARTNERSHIP BETWEEN COMPANIES

5.3.4 EXPANSION AND LAUNCH OF PRODUCTS

5.3.5 EVENTS AND EXHIBITION

5.3.6 PHYSICIAN ADOPTION

5.4 CHALLENGES

5.4.1 CLINICAL VALIDATION

5.4.2 REGULATORY APPROVAL

5.4.3 PAYER REIMBURSEMENT

6 IMPACT OF COVID-19 ON ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET

6.1 IMPACT ON DEMAND

6.2 IMPACT ON SUPPLY

6.3 KEY INITIATIVES TAKEN BY PLAYERS DURING COVID-19

6.4 CONCLUSION

7 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE

7.1 OVERVIEW

7.2 SOLUTION/SOFTWARE

7.3 HARDWARE PRODUCTS

7.4 SERVICE

8 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 TREATMENT/CARE-RELATED APPLIACTIONS

8.2.1 DIABETES

8.2.2 CENTRAL NERVOUS SYSTEM DISORDERS

8.2.3 SMOKING CESSATION

8.2.4 CHRONIC RESPIRATORY DISEASES

8.2.5 MUSCULOSKELETAL DISORDER

8.2.6 CARDIOVASCULAR DISEASES

8.2.7 MEDICATION ADHERENCE

8.2.8 GASTROINTESTINAL DISORDERS

8.2.9 REHABILITATION AND PATIENT CARE

8.2.10 SUBSTANCE USE DISORDER AND ADDICTION MANAGEMENT

8.2.11 OTHER TREATMENT/ CARE RELATED APPLICATIONS

8.3 PREVENTIVE APPLICATIONS

8.3.1 PREDIABETES

8.3.2 OBESITY

8.3.3 NUTRITION

8.3.4 LIFESTYLE MANAGEMENT

8.3.5 OTHER PREVENTIVE APPLICATIONS

9 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE

9.1 OVERVIEW

9.2 GROUP PURCHASE ORGANIZATION

9.2.1 SOLUTIONS/ SOFTWARE

9.2.2 HARDWARE PRODUCT

9.2.3 SERVICE

9.3 INDIVIDUAL

9.3.1 SOLUTIONS/ SOFTWARE

9.3.2 HARDWARE PRODUCT

9.3.3 SERVICE

10 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL

10.1 OVERVIEW

10.2 B2B

10.2.1 PAYERS

10.2.2 EMPLOYERS

10.2.3 PHARMA COMPANIES

10.2.4 PROVIDERS

10.2.5 OTHER BUYERS

10.3 B2C

10.3.1 CAREGIVERS

10.3.2 PATIENTS

11 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY GEOGRAPHY

11.1 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY

11.1.1 JAPAN

11.1.2 CHINA

11.1.3 AUSTRALIA

11.1.4 SOUTH KOREA

11.1.5 INDIA

11.1.6 SINGAPORE

11.1.7 THAILAND

11.1.8 MALAYSIA

11.1.9 INDONESIA

11.1.10 PHILIPPINES

11.1.11 REST OF ASIA-PACIFIC

12 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13 SWOT

14 COMPANY PROFILE

14.1 FITBIT,INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENTS

14.2 LIVONGO

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 RESMED

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 OMADA HEALTH, INC.

14.4.1 COMPANY SNAPSHOT

14.4.2 COMPANY SHARE ANALYSIS

14.4.3 PRODUCT PORTFOLIO

14.4.4 RECENT DEVELOPMENTS

14.5 GINGER

14.5.1 COMPANY SNAPSHOT

14.5.2 PRODUCT PORTFOLIO

14.5.3 RECENT DEVELOPMENT

14.6 SAMSUNG

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENT

14.7 MINDSTRONG HEALTH

14.7.1 COMPANY SNAPSHOT

14.7.2 SERVICE PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

 

14.8 2MORROW INC.

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 AKILI INTERACTIVE LABS, INC.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

14.1 ATENTIV

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 AYOGO HEALTH INC.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENTS

14.12 BETTER THERAPEUTICS, INC

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 CANARY HEALTH

14.13.1 COMPANY SNAPSHOT

14.13.2 SOLUTION PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 CLICK THERAPEUTICS, INC.

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENTS

14.15 COGNIFIT

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENTS

14.16 COGNOA

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

14.17 GAIA AG

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENTS

14.18 HAPPIFY, INC.

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENTS

14.19 KAIA HEALTH

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 MANGO HEALTH

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENTS

14.21 NATURAL CYCLES USA CORP

14.21.1 COMPANY SNAPSHOT

14.21.2 PRODUCT PORTFOLIO

14.21.3 RECENT DEVELOPMENT

14.22 NOOM, INC.

14.22.1 COMPANY SNAPSHOT

14.22.2 PRODUCT PORTFOLIO

14.22.3 RECENT DEVELOPMENT

14.23 PEAR THERAPEUTICS, INC.

14.23.1 COMPANY SNAPSHOT

14.23.2 PRODUCT PORTFOLIO

14.23.3 RECENT DEVELOPMENTS

14.24 SMARTPATIENT GMBH

14.24.1 COMPANY SNAPSHOT

14.24.2 PRODUCT PORTFOLIO

14.24.3 RECENT DEVELOPMENT

14.25 VOLUNTIS

14.25.1 COMPANY SNAPSHOT

14.25.2 REVENUE ANALYSIS

14.25.3 PRODUCT PORTFOLIO

14.25.4 RECENT DEVELOPMENTS

14.26 WELLDOC, INC.

14.26.1 COMPANY SNAPSHOT

14.26.2 PRODUCT PORTFOLIO

14.26.3 RECENT DEVELOPMENTS

14.27 WELLTHY THERAPEUTICS PVT LTD

14.27.1 COMPANY SNAPSHOT

14.27.2 PRODUCT PORTFOLIO

14.27.3 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

表のリスト

LIST OF TABLES

TABLE 1 REGULATORY FRAMEWORK

TABLE 2 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)

TABLE 3 ASIA-PACIFIC SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION))

TABLE 4 ASIA-PACIFIC HARDWARE PRODUCTS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 ASIA-PACIFIC SERVICE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2020-2028 (USD MILLION)

TABLE 7 ASIA-PACIFIC TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 ASIA-PACIFIC TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 9 ASIA-PACIFIC PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 ASIA-PACIFIC PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 11 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2020-2028 (USD MILLION)

TABLE 12 ASIA-PACIFIC GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 ASIA-PACIFIC GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 14 ASIA-PACIFIC INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 ASIA-PACIFIC INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 16 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2020-2028 (USD MILLION)

TABLE 17 ASIA-PACIFIC B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 ASIA-PACIFIC B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 19 ASIA-PACIFIC B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 ASIA-PACIFIC B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 21 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 22 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 23 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 24 ASIA-PACIFIC TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 25 ASIA-PACIFIC PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 26 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 27 ASIA-PACIFIC GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 28 ASIA-PACIFIC INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 29 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 30 ASIA-PACIFIC B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 32 JAPAN DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 33 JAPAN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 34 JAPAN TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 35 JAPAN PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 36 JAPAN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 37 JAPAN GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 38 JAPAN INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 39 JAPAN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 40 JAPAN B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 41 JAPAN B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 42 CHINA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 43 CHINA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 44 CHINA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 45 CHINA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 46 CHINA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 47 CHINA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 48 CHINA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 49 CHINA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 50 CHINA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 51 CHINA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 52 AUSTRALIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 53 AUSTRALIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 54 AUSTRALIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 55 AUSTRALIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 56 AUSTRALIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 57 AUSTRALIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 58 AUSTRALIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 59 AUSTRALIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 60 AUSTRALIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 61 AUSTRALIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 62 SOUTH KOREA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 63 SOUTH KOREA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 64 SOUTH KOREA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 65 SOUTH KOREA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 66 SOUTH KOREA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 67 SOUTH KOREA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 68 SOUTH KOREA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 69 SOUTH KOREA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 70 SOUTH KOREA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 71 SOUTH KOREA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 72 INDIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 73 INDIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 74 INDIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 75 INDIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 76 INDIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 77 INDIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 78 INDIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 79 INDIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 80 INDIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 81 INDIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 82 SINGAPORE DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 83 SINGAPORE DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 84 SINGAPORE TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 85 SINGAPORE PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 86 SINGAPORE DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 87 SINGAPORE GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 88 SINGAPORE INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 89 SINGAPORE DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 90 SINGAPORE B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 91 SINGAPORE B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 92 THAILAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 93 THAILAND DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 94 THAILAND TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 95 THAILAND PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 96 THAILAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 97 THAILAND GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 98 THAILAND INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 99 THAILAND DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 100 THAILAND B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 101 THAILAND B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 102 MALAYSIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 103 MALAYSIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 104 MALAYSIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 105 MALAYSIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 106 MALAYSIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 107 MALAYSIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 108 MALAYSIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 109 MALAYSIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 110 MALAYSIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 111 MALAYSIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 112 INDONESIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 113 INDONESIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 114 INDONESIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 115 INDONESIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 116 INDONESIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 117 INDONESIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 118 INDONESIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 119 INDONESIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 120 INDONESIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 121 INDONESIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 122 PHILIPPINES DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

TABLE 123 PHILIPPINES DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 124 PHILIPPINES TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 125 PHILIPPINES PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 126 PHILIPPINES DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 127 PHILIPPINES GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 128 PHILIPPINES INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)

TABLE 129 PHILIPPINES DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 130 PHILIPPINES B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 131 PHILIPPINES B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)

TABLE 132 REST OF ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)

 

図表一覧

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET : DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: MULTIVARIATE MODELLING

FIGURE 7 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 ASIA-PACIFIC IS EXPECTED TO DOMINATE THE GLOBA DIGITAL THERAPEUTIC (DTX) MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 INCREASING DEMAND OF DIGITAL THERAPEUTICS WORLDWIDE DUE TO PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE MARKET GROWTH IN THE FORECAST PERIOD OF 2021 TO 2028.

FIGURE 13 SOLUTIONS/SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET IN 2021 & 2028

FIGURE 14 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR DIGITAL THERAPEUTICS (DTX) MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET

FIGURE 16 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020

FIGURE 17 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)

FIGURE 18 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, CAGR (2021-2028)

FIGURE 19 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, LIFELINE CURVE

FIGURE 20 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020

FIGURE 21 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020-2028 (USD MILLION)

FIGURE 22 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 23 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 24 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020

FIGURE 25 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020-2028 (USD MILLION)

FIGURE 26 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, CAGR (2021-2028)

FIGURE 27 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, LIFELINE CURVE

FIGURE 28 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020

FIGURE 29 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020-2028 (USD MILLION)

FIGURE 30 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, CAGR (2021-2028)

FIGURE 31 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, LIFELINE CURVE

FIGURE 32 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: SNAPSHOT (2020)

FIGURE 33 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020)

FIGURE 34 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2021 & 2028)

FIGURE 35 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020 & 2028)

FIGURE 36 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE (2021-2028)

FIGURE 37 ASIA-PACIFIC DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY SHARE 2020 (%)

 

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The Asia-Pacific Digital Therapeutic (DTx) Market size will be worth USD 20.32 billion by 2031.
The Asia-Pacific Digital Therapeutic (DTx) Market growth rate will be 23.4% by 2031.
Increasing Prevalence of Chronic Diseases and Growing Regulatory Support and Validation are the growth drivers of the Asia-Pacific Digital Therapeutic (DTx) Market.
The product and service type, application, purchase mode and sales channel are the factors on which the Asia-Pacific Digital Therapeutic (DTx) Market research is based.
The major companies in the Asia-Pacific Digital Therapeutic (DTx) Market are Omada Health Inc. (U.S.), Welldoc, Inc. (U.S.), 2Morrow, Inc. (U.S.), Teladoc Health, Inc. (U.S.), Propeller HealtH (U.S.), Fitbit LLC (U.S.), Canary Health (U.S.), Noom, Inc. (U.S.), Pear Therapeutics, Inc. (U.S.), Akili Interactive Labs, Inc. (U.S.), Hygieia (U.S.), DarioHealth Corp. (Israel), BigHealth (U.K.), GAIA AG (Germany), Limbix Health, Inc. (U.S.), and Mango Health (U.S.).

関連ページを閲覧する

Banner